Taken together, these findings suggest that Pax-2 is overexpressed in pRCC and ccRCC, whereas in chrRCC it is underexpressed, when compared to their normal cell counterparts. The gene discussed is PAX2; the disease is nonpapillary renal cell carcinoma.